These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 24950979)

  • 1. Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO).
    Ciardiello F; Arnold D; Casali PG; Cervantes A; Douillard JY; Eggermont A; Eniu A; McGregor K; Peters S; Piccart M; Popescu R; Van Cutsem E; Zielinski C; Stahel R
    Ann Oncol; 2014 Sep; 25(9):1673-1678. PubMed ID: 24950979
    [No Abstract]   [Full Text] [Related]  

  • 2. Delivering on the promise of precision cancer medicine.
    Berger MF; Van Allen EM
    Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852
    [No Abstract]   [Full Text] [Related]  

  • 3. The European Society for Medical Oncology (ESMO) Precision Medicine Glossary.
    Yates LR; Seoane J; Le Tourneau C; Siu LL; Marais R; Michiels S; Soria JC; Campbell P; Normanno N; Scarpa A; Reis-Filho JS; Rodon J; Swanton C; Andre F
    Ann Oncol; 2018 Jan; 29(1):30-35. PubMed ID: 29140430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT).
    Mateo J; Chakravarty D; Dienstmann R; Jezdic S; Gonzalez-Perez A; Lopez-Bigas N; Ng CKY; Bedard PL; Tortora G; Douillard JY; Van Allen EM; Schultz N; Swanton C; André F; Pusztai L
    Ann Oncol; 2018 Sep; 29(9):1895-1902. PubMed ID: 30137196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovative methods for biomarker discovery in the evaluation and development of cancer precision therapies.
    Umelo IA; Costanza B; Castronovo V
    Cancer Metastasis Rev; 2018 Mar; 37(1):125-145. PubMed ID: 29392535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized Medicine: Genomics Trials in Oncology.
    Hayes DF; Schott AF
    Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cancer: three eras of personalized medicine].
    Jordan B
    Med Sci (Paris); 2017 Oct; 33(10):905-908. PubMed ID: 28994388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies in functional proteomics: Unveiling the pathways to precision oncology.
    Favicchio R; Thepaut C; Zhang H; Arends R; Stebbing J; Giamas G
    Cancer Lett; 2016 Nov; 382(1):86-94. PubMed ID: 26850375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group.
    Mandelker D; Donoghue M; Talukdar S; Bandlamudi C; Srinivasan P; Vivek M; Jezdic S; Hanson H; Snape K; Kulkarni A; Hawkes L; Douillard JY; Wallace SE; Rial-Sebbag E; Meric-Bersntam F; George A; Chubb D; Loveday C; Ladanyi M; Berger MF; Taylor BS; Turnbull C
    Ann Oncol; 2019 Aug; 30(8):1221-1231. PubMed ID: 31050713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Special series on comparative effectiveness research: challenges to real-world solutions to quality improvement in personalized medicine.
    Browman GP
    J Clin Oncol; 2012 Dec; 30(34):4188-91. PubMed ID: 23071250
    [No Abstract]   [Full Text] [Related]  

  • 11. Revolutionizing Precision Oncology through Collaborative Proteogenomics and Data Sharing.
    Rodriguez H; Pennington SR
    Cell; 2018 Apr; 173(3):535-539. PubMed ID: 29677503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Medicine Takes the Stage, Again!
    Tempero M
    J Natl Compr Canc Netw; 2018 Jul; 16(7):795. PubMed ID: 30006420
    [No Abstract]   [Full Text] [Related]  

  • 13. Pediatric oncology enters an era of precision medicine.
    Seibel NL; Janeway K; Allen CE; Chi SN; Cho YJ; Glade Bender JL; Kim A; Laetsch TW; Irwin MS; Takebe N; Tricoli JV; Parsons DW
    Curr Probl Cancer; 2017; 41(3):194-200. PubMed ID: 28343740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights on personalized cancer treatments: a report from the ESMO Congress.
    Ciardiello F; Jezdic S
    Expert Rev Anticancer Ther; 2011 Jan; 11(1):21-3. PubMed ID: 21166507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-generation sequencing of cancer genomes: lessons learned.
    Corrigan AE; Taylor R; Rallis KS
    Future Oncol; 2021 Nov; 17(31):4041-4044. PubMed ID: 34431364
    [No Abstract]   [Full Text] [Related]  

  • 16. Implementing precision cancer medicine in the genomic era.
    Chen HZ; Bonneville R; Roychowdhury S
    Semin Cancer Biol; 2019 Apr; 55():16-27. PubMed ID: 29857039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of cancer treatment using precision oncogenomics.
    Wartman LD
    Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29610395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-Generation Sequencing in Oncology in the Era of Precision Medicine.
    Blumenthal GM; Mansfield E; Pazdur R
    JAMA Oncol; 2016 Jan; 2(1):13-4. PubMed ID: 26540172
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancer Biomarkers in the era of precision oncology: Addressing the needs of patients and health systems.
    Normanno N; Apostolidis K; de Lorenzo F; Beer PA; Henderson R; Sullivan R; Biankin AV; Horgan D; Lawler M
    Semin Cancer Biol; 2022 Sep; 84():293-301. PubMed ID: 34389490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bringing Precision Medicine to Community Oncologists.
    Cancer Discov; 2017 Jan; 7(1):6-7. PubMed ID: 27864232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.